| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.4 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | pitstop2 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.4 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | -0.041 | 0.4 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | palmostatin B | CTRPv2 | pan-cancer | AAC | -0.038 | 0.4 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.04 | 0.4 |